2.44
price down icon3.56%   -0.09
after-market Dopo l'orario di chiusura: 2.32 -0.12 -4.92%
loading
Precedente Chiudi:
$2.53
Aprire:
$2.48
Volume 24 ore:
32,667
Relative Volume:
0.04
Capitalizzazione di mercato:
$4.11M
Reddito:
$502.40K
Utile/perdita netta:
$-7.91M
Rapporto P/E:
-0.2447
EPS:
-9.972
Flusso di cassa netto:
$-4.32M
1 W Prestazione:
+12.96%
1M Prestazione:
+21.39%
6M Prestazione:
-63.58%
1 anno Prestazione:
-84.75%
Intervallo 1D:
Value
$2.40
$2.48
Intervallo di 1 settimana:
Value
$1.91
$2.5475
Portata 52W:
Value
$1.41
$35.99

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
Nome
60 Degrees Pharmaceuticals Inc
Name
Telefono
202-327-5422
Name
Indirizzo
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
Dipendente
3
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
SXTP's Discussions on Twitter

Confronta SXTP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SXTP
60 Degrees Pharmaceuticals Inc
2.44 4.11M 502.40K -7.91M -4.32M -9.972
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.40 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
318.25 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.04 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
254.49 28.51B 3.81B -644.79M -669.77M -6.24

60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie

pulisher
Jun 14, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Cut to Sell at Wall Street Zen - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given “Sell (E+)” Rating at Weiss Ratings - Defense World

Jun 12, 2025
pulisher
Jun 07, 2025

60 Degrees Pharmaceuticals and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Daily Jeffersonian

Jun 07, 2025
pulisher
Jun 07, 2025

Jaguar Health to Conduct Fireside Chat June 10 Regarding Company's Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners’ Spring 2025 Spotlight Series - The Holland Sentinel

Jun 07, 2025
pulisher
Jun 06, 2025

Research Analysts Set Expectations for SXTP Q2 Earnings - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Insider Buying: Cheryl Xu Acquires Additional Shares of 60 Degre - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Insider Buying: Cheryl Xu Acquires Additional Shares of 60 Degrees Pharmaceuticals Inc (SXTP) - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

60 degrees pharmaceuticals director Cheryl Xu purchases $14,410 in stock By Investing.com - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 05, 2025

60 degrees pharmaceuticals director Cheryl Xu purchases $14,410 in stock - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

60 degrees pharmaceuticals director Cheryl Xu buys $14,410 in stock - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

60 degrees pharmaceuticals director Cheryl Xu buys $14,410 in stock By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

New to The Street Signs MUSQ ETF to Multi-Part Media Series Featuring Long-Form Interviews, Earned Media, and TV Commercials - Sarasota Herald-Tribune

Jun 05, 2025
pulisher
Jun 05, 2025

60 Degrees Pharmaceuticals Inc (SXTP) Has A Gold Mine On Its Hands - Stocksregister

Jun 05, 2025
pulisher
Jun 05, 2025

Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals - mx.advfn.com

Jun 05, 2025
pulisher
Jun 05, 2025

60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format - mx.advfn.com

Jun 05, 2025
pulisher
Jun 05, 2025

SXTP60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - mx.advfn.com

Jun 05, 2025
pulisher
Jun 05, 2025

60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - mx.advfn.com

Jun 05, 2025
pulisher
Jun 04, 2025

60 Degrees Pharmaceuticals introduces new malaria drug packaging By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

60 Degrees Pharmaceuticals (SXTP) Launches New ARAKODA Packaging for Short Trips | SXTP Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

60 Degrees announces results from an insurance claims analysis on babesiosis - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Only FDA-Approved Weekly Malaria Prevention Drug Now Available in Travel-Friendly 8-Count Package - Stock Titan

Jun 04, 2025
pulisher
Jun 03, 2025

60 Degrees Pharmaceuticals (SXTP) Reveals New Insights on Babesi - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

60 Degrees Pharmaceuticals (SXTP) Reveals New Insights on Babesiosis and Chronic Fatigue | SXTP Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Gulf Keystone Petroleum (OTCMKTS:GUKYF) Trading 5.9% Higher – Should You Buy? - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

PROG Holdings, Inc. (NYSE:PRG) Short Interest Update - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Mobileye Global Inc. (NASDAQ:MBLY) Given Consensus Rating of “Hold” by Analysts - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Polar Power, Inc. (NASDAQ:POLA) Sees Significant Decline in Short Interest - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Woodside Energy Group Ltd (NYSE:WDS) Given Consensus Recommendation of “Hold” by Analysts - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Goldmoney (OTCMKTS:XAUMF) Shares Up 0.6% – Still a Buy? - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

FTI Foodtech International (CVE:FTI) Stock Price Up 2.3% – Still a Buy? - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Stelco (OTCMKTS:STZHF) Shares Up 1.1% – What’s Next? - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Trevi Therapeutics (NASDAQ:TRVI) Given “Buy” Rating at D. Boral Capital - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

iShares ESG Aware MSCI EM ETF (NASDAQ:ESGE) Short Interest Update - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Southwest Gas Holdings, Inc. (NYSE:SWX) Sees Large Increase in Short Interest - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Muscle Maker (NASDAQ:GRIL) Trading Down 4.2% – What’s Next? - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Price Target Raised to $7.00 at Ascendiant Capital Markets - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

CIIG Merger (OTCMKTS:CIICU) Trading Down 5.1% – Here’s What Happened - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Kidoz (CVE:KIDZ) Trading 2.9% Higher – Should You Buy? - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Ascendiant Capital lowers 60 Degrees stock price target to $7 By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

Ascendiant Capital Raises Price Target for SXTP to $7.00 | SXTP Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Ascendiant Capital lowers 60 Degrees stock price target to $7 - Investing.com

Jun 02, 2025
pulisher
May 31, 2025

Ulta Beauty (NASDAQ:ULTA) Shares Gap Up Following Better-Than-Expected Earnings - Defense World

May 31, 2025
pulisher
May 31, 2025

Uber Technologies, Inc. (NYSE:UBER) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

May 31, 2025
pulisher
May 27, 2025

4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World

May 27, 2025
pulisher
May 27, 2025

Research Analysts’ Recent Ratings Changes for Adaptimmune Therapeutics (ADAP) - Defense World

May 27, 2025
pulisher
May 27, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given Sell (E+) Rating at Weiss Ratings - Defense World

May 27, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Acquires New Position in FARO Technologies, Inc. (NASDAQ:FARO) - Defense World

May 26, 2025
pulisher
May 25, 2025

Live Radar: Track thunderstorms as they move across Southeast Georgia and Northeast Florida (Video) - Spot On Florida

May 25, 2025
pulisher
May 25, 2025

Cetera Investment Advisers Has $876,000 Stock Holdings in Goldman Sachs BDC, Inc. (NYSE:GSBD) - Defense World

May 25, 2025

60 Degrees Pharmaceuticals Inc Azioni (SXTP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

60 Degrees Pharmaceuticals Inc Azioni (SXTP) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
XU CHERYL
Director
Dec 13 '24
Buy
1.56
6,000
9,375
52,078
XU CHERYL
Director
Dec 12 '24
Buy
1.82
5,000
9,125
46,078
XU CHERYL
Director
Dec 16 '24
Buy
1.45
2,000
2,900
54,078
DOW GEOFFREY S
President and CEO
Dec 09 '24
Buy
1.27
35,823
45,563
94,580
DOW GEOFFREY S
President and CEO
Dec 06 '24
Buy
1.20
20,579
24,672
58,757
DOW GEOFFREY S
President and CEO
Dec 05 '24
Buy
1.11
17,549
19,520
38,178
DOW GEOFFREY S
President and CEO
Nov 21 '24
Buy
0.91
3,500
3,195
20,629
DOW GEOFFREY S
President and CEO
Nov 19 '24
Buy
0.90
2,500
2,248
16,129
DOW GEOFFREY S
President and CEO
Nov 20 '24
Buy
0.92
1,000
924
17,129
XU CHERYL
Director
Aug 27 '24
Buy
1.70
5,000
8,500
41,078
$20.73
price up icon 1.02%
$35.27
price down icon 1.78%
$21.32
price up icon 0.24%
$101.74
price down icon 2.97%
$106.14
price up icon 1.28%
biotechnology ONC
$254.49
price down icon 4.73%
Capitalizzazione:     |  Volume (24 ore):